Back to NBIX
Sumitomo Mitsui Trust Group, Inc. → NBIX
Sumitomo Mitsui Trust Group, Inc. NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
4
Latest value
$29.9M
Q3 2026
Peak value
$36.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $28.7M |
| Q1 2026 | $29M |
| Q2 2026 | $36.3M |
| Q3 2026 | $29.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $29.9M | 211.0K | — | — |
| Q2 2026 | $36.3M | 215.5K | — | — |
| Q1 2026 | $29M | 220.4K | — | — |
| Q4 2025 | $28.7M | 202.7K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M